Corporate Writing

Turnkey editorial support isn’t a pipe dream.

As an experienced business writer, I can interview executives and other subject matter experts intelligently and efficiently, develop concepts and outlines that you can approve with confidence, and bring projects to a successful conclusion.

Quite simply, when you put a project in my hands, you can be assured of getting excellent copy that is delivered on deadline at a price that is within your budget. I can offer hourly rates or project fees depending on your needs and references are available upon request.

Samples (all files PDFs)
Brochures

Genpact Banking and Financial Services

White Papers

The Future is Now: Channel Sales and Service Innovation

SAS 70 Certification: A New Imperative for Meeting Customer Needs

How Managing Political Risk Improves Global Business Performance

Capturing Synergies During Integration: How to complete the M&A integration process, minimize disruptions, and achieve desired synergies.

Information Technology: How to complete the M&A integration process, minimize disruptions, and achieve desired synergies.

Ghostwriting

Alternative Cross-Border Financing for the Middle Market

Scalable Injury Prevention: Safety Assurance is a Key Business Advantage

The Costly Connection Between Pain and Lost Productivity

Ghost Blogging

After the Ink Dries

Newsletters

Making Smart Risk Retention and Risk Transfer Decisions

Navigating the Bankruptcy Matrix

QuickBrief: Protecting Sensitive Data Within Retail and Consumer Companies

Retirement Plan Sponsor Newsletter

Articles

Real estate and the California biomedical industry: Is California resting on its laurels?

Go Green: Environmental Opportunities for the Future

The Power and Promise of Incentives

Managing a Company and a Career During a Recession

Case Studies

How Implementing A Customized Lean Sigma Methodology Drives Continuous Improvement

Abbott Diabetes Care: Driven by Competition and Differentiation*

Edwards LifeSciences: Maintaining the Balance*

Genentech: A Cautionary Tale?*

*Excerpt from California Biomedical Industry Report